Access to Euripid for non-participants
All partners of the EURIPID collaboration, the European Commission, Eurostat and the European Medicines Agency (EMA) have access to the database. The terms and conditions for the use of data and information are specified in the legal framework of the EURIPID collaboration. In order to increase transparency, Since the EURIPID collaboration is committed to improve transparency in the area of pharmaceutical prices / pricing, it aims to enable wider access to data within the remits of each partners data provision requirements. On an aggregated level EURIPID data can be shared by participants and used for research and decision making purposes.
Interested non-participating national competent authorities for pricing and reimbursement in European countries can contact the EURIPID ccollaboration and apply for membership. New members have to be approved by the Borad of Participants. Non-EU/EEA countries are allowed to apply for membership but cannot receive funding from the European Union.
Interested non-participants can contact the Euripid collaboration and apply for membership. New members have to be approved by the Borad of Participants. Non-EU/EEA countries are allowed to apply for membership but cannot receive funding from the European Union.
Provision of EURIPID data to researchers
1) Submission of application form
At first, an application form needs to be filled out by the applicant. Applications for EUIRPID data have to fulfil the following specific requirements:
- Name of researcher / representant of the research team
- Name of tutor/supervisor
- Name of academic institution / Research team
- Research plan
- Objective of research
- Expected benefits of research
- Sponsors of research
- Description of the requested information
- geographic coverage
- data scope (price, volume)
- product type
- if quality review is requested (Yes/No)
Confidential disclosure agreement: With the submission of the application form, the applicant agrees signs a confidential disclosure agreement and the EURIPID collaboration countersigns after a positive decision of the Board of Participants (BoP).
Agreement to share results with the Euripid-collaboration: With the submission of the application form, the applicant agrees to share the results of the research with the EURIPID collaboration.
If you are interested in applying for access to EURIPID data, please fill out the application form here.
2) Review and assessment of application
After the applicant submitted the application, the EURIPID team reviews the application for completeness. Further, applications may require additional programming of SQL-specific queries which will be assessed by the EURIPID team. The EURIPID Executive Committee assesses complete applications with regard to content. If the Executive Committee endorses the application, a formal voting procedure by the BoP will be initiated.
3) Vote on application by BoP
The BoP is responsible for making a decision on applications on a case-by-case basis. The prodecure takes approximately three weeks from the submission of the application (Step 1) to a decision of the BoP (Step 3). The applicant will be informed by the EURIPID team if the decision of the BoP was positive or negative. In case of a negative decision, the applicant will be informed by the EURIPID team on the reasons of rejecting the application. In case of a positive decision, the applicant will be informed by the EURIPID team on the reasons of rejecting the application. In case of a positive decision, the applicant will be informed by the EURIPID team on the further procedure.
4) Data provision
After a positive decision of the BoP, there are two different procedures.
4a – Notification & data extract: If the request can be fulfilled with available means, the EURIPID team informs the applicant about the positive decision of the BoP and provides the requested data extract.
4b – Query against payment: If the request cannot be fulfilled with available means and additional SQL programming is necessary, the EURIPID team informs the applicant to contact the information provision service of the Hungarian National Institute of Health Insurance Fund (NEAK). The information provision services initiates the necessary extra query against payment and provides the data extract.
5) Signature of the Confidentiality Disclosure Agreement
The research team or individual researcher must sign a confidential disclosure agreement when applying for data access confirming that no product level data will be shared with Third parties. Additionally, the applicant has to sign an agreement that the results of the research will be shared with the EURPID collaboration. After a positive decision of the BoP, the EURIPID collaboration countersigns the Confidentiality Disclosure Agreement.
6) Start Research
After the signature of the Confidentiality Disclosure Agreement and the agreement to share the results if the research, the applicant can start the research. The research should be strictly non-commercial and serve public interest, as defined in the WHA resolution on price transparency. Requests for bachelor or master-theses only shall be excluded.
7) Quality Review (optional)
If the applicant requested a quality check of the research based on EURIPID data in the application, the EURIPID team will conduct the quality review.
8) Notification prior to publication
The researcher has to share the final analysis with the EURIPID collaboration for publication on the EURIPID public website once the article is published. The Euripid team reserves the right to be listed as co-author in publications, especially when a quality review of the analysis and/or input to the methodology was provided.